Tumor-Specific Fluorescence-Guided Surgery for Pancreatic Cancer Using Panitumumab-IRDye800CW: A Phase I Dose-Escalation study

BACKGROUND: Complete surgical resection remains the primary curative option for pancreatic ductal adenocarcinoma (PDAC) with positive margins in 30%−70% of patients. The present study aimed to evaluate the use of intraoperative tumor-specific imaging to enhance surgeons’ ability to detect visually-o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lancet Gastroenterol Hepatol
Main Authors: Lu, Guolan, van den Berg, Nynke S., Martin, Brock A., Nishio, Naoki, Hart, Zachary P., van Keulen, Stan, Fakurnejad, Shayan, Chirita, Stefania U., Raymundo, Roan C., Yi, Grace, Zhou, Quan, Fisher, George A., Rosenthal, Eben L, Poultsides, George A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7367758/
https://ncbi.nlm.nih.gov/pubmed/32416764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(20)30088-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados